The Dual Amylin and Calcitonin Receptor Agonist, KBP-066, Induces an Equally Potent Weight Loss Across a Broad Dose Range While Higher Doses May Further Improve Insulin Action
Sonne, Nina, Larsen, Anna Thorsø, Andreassen, Kim Vietz, Karsdal, Morten Asser, Henriksen, KimVolume:
373
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.119.263723
Date:
April, 2020
File:
PDF, 1.51 MB
2020